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Insulin-like peptide 3 (INSL3) and its specific receptor RXFP2 are both expressed by
theca interna cells of the growing antral follicle where they form an essential regulatory
element in the production of the steroid precursor androstenedione. Using primary
cultures of bovine theca cells from the mid follicular phase together with steroid
agonists and antagonists we have examined how ovarian steroids modulate INSL3
expression. Transcript analysis shows that these cells express estrogen receptors α and
β, androgen and progesterone receptors, besides the orphan nuclear receptors SF1 and
nur77. Whereas, exogenous androgens have little or no effect, the androgen antagonist
bicalutamide stimulates INSL3 production. In contrast, estrogen receptor agonists, as
also progesterone, are stimulatory. Importantly, estrogen receptor signaling is convergent
with the protein kinase A signaling pathway activated by LH, such that the estrogen
receptor antagonist can inhibit the mild stimulatory effect of LH, and vice versa the PKA
antagonist H89 blocks stimulation by estradiol. A significant finding is that the major
steroid metabolite androstenedione appears to act predominantly as an estrogen and
not an androgen in this system. Transfection of INSL3 gene promoter-reporter constructs
together with various steroid receptor expression plasmids supports these findings
and shows that steroid action uses non-classical pathways not requiring canonical
steroid-responsive elements in the proximal promoter region. Together, the results
indicate that increasing estrogens in the follicular phase stimulate a feedforward loop
driving INSL3 signaling and thereby promoting steroidogenesis in the growing antral
follicle until the LH surge which effectively switches off INSL3 expression.
Keywords: insulin-like peptide 3, RXFP2, testosterone, androstenedione, estradiol, ovarian theca cells, PCOS
INTRODUCTION
According to the “two-cell two-gonadotropin” hypothesis, the two major somatic cell types of the
ovarian antral follicle mutually interact to attain coordinated and optimized function during the
estrous cycle, leading to the ovulation of a mature and fertile oocyte (Hillier et al., 1994). Part
of this interaction involves the production of steroid hormones by both cell types, respectively
the theca interna cells (TC) and the granulosa cells (GC). In the small (3–5mm diameter) to
medium (6–8mmdiameter) follicles of themid cycle, prior to the LH surge, TC produce principally
androstenedione (A4) via the15 pathway, but also smaller amounts of testosterone and DHEA, as
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well as some progesterone via the 14 pathway (Berndtson et al.,
1995; Spicer, 2005). Whilst TC do use cholesterol to produce
the major precursor pregnenolone, it is believed that much of
TC steroidogenesis derives from pregnenolone exported from
GC (Fortune, 1986), which reciprocally import androstenedione
and testosterone from TC, and using the enzyme aromatase
convert these into estradiol and estrone. Later, following the LH
surge, both GC and TC dedicate metabolism to the production
via the 14 pathway of progesterone in the process known
as luteinisation. The “two-cell two-gonadotropin” hypothesis
states that while the mid-cycle TC are governed uniquely by
the pituitary gonadotropin LH, mid-cycle GC rely more or less
exclusively on FSH, although some LH receptors are beginning to
be expressed there. Thus, the growing antral follicle of the cycle is
a dynamic steroidogenic tissue whose physiology is dominated
by the reciprocal interactions of GC and TC. These features
are common to both human and bovine antral follicles, and
the bovine system is recommended as an excellent model for
the equivalent physiological events in the human (Adams et al.,
2012).
Another important facet of the growing antral follicle is
that while the TC layer is supplied by vigorous capillary
vascularization, the GC layer is effectively segregated from the
circulation by a dense basal layer. Moreover, follicular fluid
accumulates high levels of steroids from both GC and TC, which
govern the environment of the oocyte as well as the follicular
somatic cells. Steroid concentrations may be very high, in the
region of 10−7 to 10−6 molar or even greater (Ivell et al., 2014).
This is a concentration which is well above the dynamic range
for conventional nuclear steroid receptors (10−10 to 10−8 molar)
but nevertheless appears to regulate important ovarian functions
such as follicle transition and maturation (Kezele and Skinner,
2003; Yang and Fortune, 2006). It seems likely that such follicular
steroids are making use of non-classical receptor mechanisms,
which may operate in a dynamic range with 10 to 100-fold less
sensitivity than for classical steroid receptor systems (Ivell et al.,
2014).
The growing ovarian follicle additionally produces a number
of mostly autocrine/paracrine acting peptide hormones and
other compounds. These include from GC, oxytocin, AMH,
relaxin, inhibin, activin, components of the renin-angiotensin
and natriuretic peptide systems, as well as BMPs (Bagnell, 1991;
Stormshak et al., 1995; Yoshimura, 1997; Webb et al., 2003;
Knight et al., 2012), and from TC, the insulin-like peptide INSL3
(Bathgate et al., 1999; Dai et al., 2017). All of these hormone-
receptor systems aid in orchestrating the growth and selection
of an antral follicle, and the maturation of an enclosed oocyte,
leading to ovulation and the synchronous preparation of the
oviduct and uterus for pregnancy.
As a model system we are using here primary cultures of
TC isolated from medium-sized (6–8mm diameter) healthy
antral follicles of bovine ovaries lacking a corpus luteum and
collected from a local slaughterhouse. As such we can be
confident that these TC will not yet have seen in vivo the
high LH concentration of the LH surge and hence not have
begun luteinisation. Moreover, we have shown previously that
such TC express the gene for INSL3 and secrete INSL3 peptide
into the culture medium (Bathgate et al., 1999; Glister et al.,
2013). INSL3 is part of an essential autocrine-paracrine network
which by activating its specific receptor (called RXFP2) on other
TC (Dai et al., 2017) is able to regulate and orchestrate the
production of androstenedione (Glister et al., 2013). Since this
is the main steroid precursor for GC, this means that INSL3 is
responsible for most steroidogenesis within the growing antral
follicle. Moreover, we have previously shown that the profile of
INSL3 secretion by waves of growing antral follicles is similar
between humans and cows (Anand-Ivell et al., 2013; Satchell
et al., 2013) suggesting that these properties are likely shared
between the two species. The objective of the present study
is to investigate whether and by how much INSL3 expression
by bovine TC can itself be modulated by follicular steroids
and the molecular mechanisms that may be involved in this.
It has been shown for the mouse Leydig cell-line MA-10, for
example, that the INSL3 gene can be modulated by estradiol
(Lague and Tremblay, 2009) and by testosterone (Lague and
Tremblay, 2008), even though there are no conventional steroid-
responsive elements within the proximal promoter region of the
mouse INSL3 gene (Koskimies et al., 1997). Rather, it appears
that the estrogen action may involve the essential binding of the
orphan receptor steroidogenic factor-1 (SF1), as has been shown
previously for the basal expression of this gene in mice, rats, and
human (Koskimies et al., 1997; Sadeghian et al., 2005; Tremblay
et al., 2009).
Together the results presented here for theca cells of growing
antral follicles show that INSL3 is part of an essential ovarian
feedforward loop driving steroidogenesis and increasing estrogen
production during the follicular phase until halted by the LH
surge.
MATERIALS AND METHODS
Cell Preparation, Culture, and Treatment
The isolation of bovine TC essentially followed Glister et al.
(2013) except that cells were cultured on uncoated plates
and flasks. Briefly, bovine ovaries were collected from the
local slaughterhouse in accordance with German, British and
European ethical regulation. They were transported to the
laboratory in warmDPBS (Dulbecco’s phosphate-buffered saline;
Gibco/Thermo-Fisher, Waltham, MA) with 2% antibiotic-
antimycotic (ABAM; Sigma-Aldrich, Dorset, UK). Follicles of
4–6mmdiameter were dissected from ovaries without an obvious
corpus luteum and granulosa cells removed. The TC layer
was peeled away and digested in Medium 199 (Sigma) with
additional collagenase IV (1 mg/ml; Sigma) and trypsin inhibitor
(100µg/ml; Sigma) in a shaking water bath at 38◦C. After
45min, cells were dissociated by repeated pipetting and digestion
continued for a further 15min. After 1 × g sedimentation for
2min the liquid phase was transferred to Medium 199 with
1% ABAM. After brief centrifugation, cells were re-suspended
in DPBS and any red blood cells removed by rapid hypotonic
shock; the resulting cells were re-suspended in TC culture-
medium [McCoy’s 5A medium (Sigma), with 1% ABAM, 2mM
L-glutamine (Gibco), 10mMHEPES (Sigma), 0.1% BSA (Biomol
GmbH, Hamburg, Germany), 10 ng/ml bovine insulin (Sigma),
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5µg/ml bovine apo-transferrin (Sigma), and 5 ng/ml sodium
selenite (Sigma)] and maintained at 38◦C with 5% CO2. TC
were seeded at ∼180,000 cells/well (48-well plate) and incubated
for 30 h, then changed to fresh TC culture-medium containing
stimulants, followed by incubation for a further 48 h at 38◦Cwith
5% CO2. The inhibitors [onapristone and RU 486 (kind gifts
from Professor Walter Elgar, Berlin, Germany), bicalutamide
(Sigma), ICI-182,780 (ICI; Tocris Bioscience, Bristol, UK), and
H89 (Sigma)] were then added, followed by estradiol (E2; Sigma),
androstenedione (A4; Fluka, Steinheim, Germany), 5 alpha-
dihydrotestosterone (DHT; Sigma), 8Br-cAMP (Sigma), or LH
from sheep pituitary (Sigma), as indicated in the figures. After
a further 48 h, the culture-medium was collected and stored at
−20◦C until INSL3 measurement (see below). All treatments
were performed in triplicate. Finally, the cells from triplicate wells
were washed with DPBS and pooled in TriZol (Ambion/Thermo-
Fischer, Waltham, MA) for RNA extraction (see below). All
experiments were repeated independently at least three times. To
test for toxicity, TC were seeded at ∼80,000 cells/well (96-well
plate), and cultured for 30 h at 38◦C with 5% CO2. Chemicals
were then applied for 48 h and cell viability measured using
the MTT (3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
bromide) assay (Invitrogen/Thermo-Fischer, Waltham, MA),
following the manufacturer’s protocol.
Bovine INSL3 Immunoassay
Bovine INSL3 secreted into the culture medium was measured
by a specific time-resolved fluorescent immunoassay (TRFIA)
previously described in detail and validated by us (Anand-Ivell
et al., 2011; Glister et al., 2013).
mRNA Isolation and RT-PCR
RNA was separated from the TriZol extracts by addition of 0.2
vol chloroform (Sigma) and centrifugation at 2,000 × g for
10min; the aqueous phase containing the RNA was precipitated
with 0.5 vol isopropanol (Sigma), pelleted by centrifugation and
washed twice in 80% EtOH. The RNA pellet was air-dried,
dissolved in RNAse-free water (Ambion) and stored in −80◦C.
To avoid any DNA contamination, the extracted RNA was
treated using the TURBO DNAse-free kit (Ambion), adhering
to the manufacturer’s protocol. RNA quantity and quality was
assessed by UV spectrophotometry at 260 and 280 nm and by gel
electrophoresis to visualize the integrity and ratio of the 18S and
28S ribosomal RNA.
cDNA was prepared using the Superscript III reverse
transcriptase kit (Invitrogen /Thermo-Fischer, Waltham,
MA) primed with oligo (dT)12−18 (Invitrogen) following the
manufacturer’s protocol. The synthesized cDNA was diluted 1:5
with RNAse-free water and stored at−20◦C. RT-PCR was carried
out using the primers listed in Table 1. DNA was denatured
at 95◦C for 45 s, annealing was for 1min at the temperature
indicated in Table 1, with elongation for 1min at 72◦C, for a total
of 35 cycles. As positive control, all samples were checked for the
expression of the housekeeping gene bovine S27a (Anand-Ivell
et al., 2006). 0.25µM of the primer pair (Eurofins Genomics,
Ebersberg, Germany) were used to amplify 1 µl of cDNA,
using the Takara Sybrgreen Premix II (Takara, Shiga, Japan) for
real-time qRT-PCR in a Rotor-Gene 3000 machine (Corbett
Research, Mortlake, Australia). PCR products were validated by
melt curves and by gel electrophoresis of the final product. The
real-time qRT-PCR results were normalized against the bovine
S27a transcript (Anand-Ivell et al., 2006).
Bovine INSL3 Gene Promoter-Reporter
Constructs and Theca Cell Transfection
The sequence of the bovine INSL3 gene and upstream promoter
region was selected from the latest release of the bovine genome
project for chromosome 7 (acc. no. AC_000164.1). In analogy
to the characterized promoter regions for the human and
rat sequences (Sadeghian et al., 2005; Tremblay et al., 2009)
the proximal promoter region of the bovine INSL3 gene was
considered to be limited in the 5′ direction by the location of the
last exon 23 of the JAK3 gene. The 1,800 bp upstream promoter
sequence of the bovine INSL3 gene was independently verified
by PCR and sequencing from bovine genomic DNA (unpublished
and Suhrbier, 2000). This sequence, terminating 3′ at the putative
transcription start site, was inserted into the multiple cloning site
of the reporter construct pGL3-B (Promega, Southampton, UK)
to create the full-length promoter-reporter construct bI3_1L. A
second full-length construct (bI3_FL) was also created which
additionally included a further 10 nucleotides of the 5′ UTR
of the INSL3 mRNA sequence. Subsequently, a series of seven
5′ deletion promoter fragments of the bI3_1L construct were
prepared (bI3_2L to bI3_8L). All constructs were custom-made
and verified by GeneArt (GeneArt/Thermo-Fischer, Waltham,
MA). Expression constructs for the transcription factors human
estrogen receptor alpha (ERα), and beta (hERβ) bovine ERβ
(bERβ), bovine SF1 (all a generous gift from Dr Norbert Walther,
Hamburg, Germany, and in the vector pRcCMV) and human
androgen receptor (AR) (a kind gift fromDr Yvonne Giwercman,
Lund, Sweden, also in a CMV-driven promoter construct, AR-
pCMV4) were as previously described (Stedronsky et al., 2002;
Nenonen et al., 2010).
For transfection, the TC were cultured at a density of
1.6 million cells per T75 flask for 18 h. The cells were then
trypsinised and washed twice with DPBS (without Ca2+ or
Mg2+) (Gibco) and transfected using the Neon transfection
system (Invitrogen), following the manufacturer’s instructions.
Transfection conditions for TC were first optimized using a
GFP-expression plasmid followed by microscopic analysis (not
shown). Cells were transfected with varying combinations of
DNA at a ratio of 6 µg DNA/500,000 cells. Between 0.5 and 2
million cells were transfected in 100 µl of Buffer R in a 100 µl
Neon tip using a single pulse of 1,500 volts for 20 milliseconds.
After each transfection, the cells were diluted in antibiotic-
free medium at 250,000 cells/500 µl/well (48-well plate). Unless
otherwise stated, the ratio of promoter-reporter (luciferase)
plasmid: receptor expression plasmid: LacZ expression vector
was 2: 3: 1. As negative control for the promoter-reporter
plasmids, the pGL3-B plasmid was used which contains neither
promoter nor transcriptional enhancer sequences. The empty
vector p0GH was used to make up any DNA deficit. Transfected
cells were then treated with various stimulants and cultured
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TABLE 1 | List of oligonucleotide primers used for RT-PCR.
Transcript No. Orientation Sequence (5′-3′) Annealing Temp (◦C) Accession No.
S27a 501 Forward tcctcctgaccagcaaagactg 62 NM_174778
502 Reverse tgcttgttcttcttgggagtgg
ERα 566 Forward agggaagctcctatttgctcc 62 NM_001001443
567 Reverse cggtggatgtggtccttctct
ERβ 568 Forward gcttcgtggagctcagcctg 62 NM_174051
569 Reverse aggatcatggccttgacacaga
AR 570 Forward cagatggcagtcattcag 60–54 NM_001244127
571 Reverse cttggtgagctggtagaag touchdown
PR 593 Forward gggatgaagcatcaggctgt 61 NM_001205356
594 Reverse ttctctggcttagggcttgg
SF1 599
600
Forward
Reverse
agctgctggtttttgaccac
cgaggctgaagagaatgagg
60 NM_174403
nur77 597
598
Forward
Reverse
ctgtgtgtggggacaatgct
gcatcctctttcccgaagtg
61 NM_001075911
INSL3 574 Forward gcgcctgagaaactgtgtgg 62 NM_174365
575 Reverse gggttgatggcagttgctcg
Oligonucleotide primers were designed using the Primer3 software and the transcript sequences indicated by the accession numbers.
for 24 h in antibiotic-free culture-medium. After removal of
the medium, the cells were lysed in 70 µl of 1×passive lysis
buffer (Promega) and the transcriptional activity of promoters
determined by measuring luciferase activity in 25 µl of cell
lysate using the Luciferase Assay System (Promega) following
the manufacturer’s instructions. Luminescence was measured
immediately using a SIRIUS Luminometer (Berthold, Pforzheim,
Germany) and expressed as Relative Light Units (RLU) in relation
to β-galactosidase expression of co-transfected LacZ expressing
plasmidsmeasured in 25µl of cell lysate using the β-galactosidase
Enzyme Assay System (Promega). For each experiment, at
least three replicates were used per treatment, and each set of
treatments were repeated independently 2–4 times.
Statistics and Analysis
All data were analyzed using the Graphpad Prism version 6
package. For primary TC experiments results were analyzed using
one-way ANOVA followed by Dunnett’s multiple comparisons
test.
RESULTS
Basal Responsiveness of Cultured Bovine
TC to LH or 8Br-Camp
All TC cultures are treated or not with steroids or their inhibitors
for 48 h before measuring the cell response. In this time, TC
will also be generating limited steroids such as androstenedione,
progesterone, DHEA or testosterone (Berndtson et al., 1995;
Spicer, 2005), hence in subsequent experiments steroid receptor
antagonists are used to determine effects of such endogenous
steroids. Furthermore, it is important within this time-frame
to recognize the difference between effects of low-dose LH (or
8Br-cAMP) equivalent to mid-cycle in vivo concentrations and
high-dose LH (or 8Br-cAMP) equivalent to the levels experienced
during the LH surge and which lead to luteinisation (Berndtson
et al., 1995). Low-dose LH (100 pg/ml), like low-dose 8Br-cAMP
(100µM) leads to only a modest increase in secretion of bINSL3
into the culture medium (Figures 1A,B). In contrast, high dose
8Br-cAMP (1mM), like high-dose LH (10 ng/ml), leads to an
inhibition of bINSL3 secretion (Figures 1A,B). It should be noted
that we are using the accumulation of the peptide bINSL3 into
the culture medium as a surrogate for bINSL3 gene transcription.
That this is justified can be seen in Figure 1C, where a good
correlation (p < 0.05) is seen between bINSL3 in the culture
medium and levels of bINSL3 mRNA measured by qRT-PCR
within one experiment.
Expression of Steroid Receptors in
Cultured Bovine TC
qRT-PCR was used to verify the relative expression of transcripts
for the nuclear steroid receptors for progesterone (PR), estrogens
(ERα and ERβ), and androgens (AR) in the bovine TC under
basal culture conditions (Figure 2). All four receptors appear
to be expressed in these cells, with highest levels seen for AR,
and lowest for ERβ. Similarly, the expression levels of transcripts
for the two orphan nuclear receptors, considered most relevant
for steroidogenic enzyme expression, SF1 (NR5A1) and nur77
(NR4A1) were also measured (Figure 2), whereby both were not
as highly expressed as PR or AR, and nur77 was at a very low level
in these mid-follicular phase theca cells.
Impact of Estradiol and Estrogen Receptor
Antagonist on INSL3 Expression in Bovine
TC
Because aromatase is not expressed in TC under basal conditions,
culture medium should be free of estradiol, estrone or other
estrogens. However, in vivo, TC will be exposed to estrogens
coming from the GC compartment. Addition of estradiol to
TC shows a bell-shaped dose-response curve (Figure 3A) with
a maximum at 1 to 100 nM. Addition of the pure estrogen
receptor antagonist ICI-182,780 leads to complete inhibition of
such stimulation at low doses of estradiol, though stimulates at
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FIGURE 1 | Effect of 8Br-cAMP or LH on INSL3 production by bovine theca
internal cells. (A) Effect of low and high-dose 8Br-cAMP. (B) Effect of low and
high-dose LH. (C) Correlation between secreted INSL3 peptide concentration
and INSL3 mRNA measured by qRT-PCR in the same cells within the same
experiment. *Indicates significant difference p < 0.05.
high doses, the dose-response curve being shiftedmarkedly to the
right.
However, when ICI-182,780 alone is added to basal TC,
there is an inhibition of bINSL3 production (Figure 3B).
Further addition of low-dose LH does little to relieve this
inhibition (Figure 3B), implying that even in the absence of
exogenous estrogens, their specific nuclear receptor(s) appear to
be obligatorily involved in bINSL3 expression. The same is true
also when LH is replaced by low-dose 8Br-cAMP (Figure 3C).
Note that estradiol has little if any additive effect to that of
8Br-cAMP, in contrast to its effect on LH.
To determine at what level the pathways involving LH
or 8Br-cAMP and the estrogen receptor might interact, TC
FIGURE 2 | Relative transcript levels (×10−2) for the steroid receptors PR,
AR, ERα, and ERβ, as well as for the orphan nuclear receptors SF1 and nur77,
measured by qRT-PCR and normalized against bovine S27a transcripts, for
three independent batches of primary cultures of bovine theca interna cells
under basal conditions.
cultures were additionally treated with the protein kinase A
(PKA) inhibitor H89 (Figure 4). Both 1 and 10µM H89 led
to a significant inhibition of the estradiol-induced stimulation
(Figure 4A), without affecting cell viability, although 50µMH89
proved toxic to the cells (not shown). However, there was no
further inhibition beyond that imposed by addition of 1µM ICI-
182,780 (Figure 4B). As a control, H89 was shown to completely
block the stimulatory effect of low-dose 8Br-cAMP (Figure 4B).
Impact of Androgens on INSL3 Expression
in Bovine TC
Addition of the relatively non-metabolisable androgen
dihydrotestosterone (DHT) indicated only a modest stimulatory
effect (Figure 5A). Only 4 of 5 independent experiments
showed a significant increase above basal of 1.26 ± 0.23
(mean±SD) fold at 1 nM DHT. Also androstenedione
(Figure 5B) showed a small but significant stimulation on
basal bINSL3 production (5 of 6 independent experiments; 1.22
± 0.16 (mean±SD) fold over basal at 10 nM androstenedione).
However, when TC were treated with the specific anti-androgen
bicalutamide (Figure 5C), production of bINSL3 was markedly
stimulated with a bell-shaped response, though again only
in 4 from 6 independent experiments each at 10 or 100nM.
Remaining experiments showed no effect. This androgen
receptor antagonist is presumably inhibiting the activity of any
endogenous androgens. The positive effect of androstenedione
at <10 nM was not significantly influenced by 100 nM
bicalutamide, though could be blocked by 1µM ICI-182,780 (not
shown).
Impact of Glucocorticoids and Gestagens
on INSL3 Expression in Bovine TC
TC are known to generate a certain amount of endogenous
progesterone (Berndtson et al., 1995), besides being exposed to
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FIGURE 3 | Effect of estrogen receptor agonist (estradiol; E2) and antagonist
(ICI-182,780; ICI) on basal and low-dose LH or 8Br-cAMP stimulated INSL3
production by bovine theca internal cells. (A) E2 dose-response in the
absence (black circles) or presence (pink squares) of 10µM ICI. (B) Effect of
E2 and/or ICI on low-dose LH stimulated INSL3 production. (C) Effect of E2
and/or ICI on low-dose 8Br-cAMP stimulated INSL3 production. Statistical
significance p < 0.05: a, vs. basal control; b, vs. LH or 8Br-cAMP control.
gestagens and glucocorticoids in vivo. In order to check for effects
of these steroids on bINSL3 production, cultured TC under basal
conditions were treated with the progesterone/glucocorticoid
receptor antagonist RU486 (Figure 6B). There is a marked
dose-dependent inhibition implying the involvement of either
activated PR or GR in bINSL3 production. However, the
glucocorticoid dexamethasone is completely without effect at
various concentrations (Figure 6A), nor does it reverse the
inhibitory effect of RU486 (Figure 6B). A similar inhibition
was also seen when using the pure PR antagonist onapristone
(Figure 6C), confirming that activated PR rather than GR
is involved in the expression of INSL3 in bovine theca
cells.
Analysis of the Proximal Promoter of the
Bovine INSL3 Gene
Approximately 1,800 bp of the proximal promoter region
sequence upstream of the first exon of the bovine INSL3
gene on chromosome 7 and immediately downstream of the
JAK3 gene was derived from the latest edition of the bovine
genome project. This sequence was confirmed also by genomic
cloning and sequence analysis (unpublished and Suhrbier,
2000). Bioinformatic analysis of this promoter region identified
three potential sites for SF-1 binding (Figure 7) though no
other consensus motifs representing canonical steroid receptor
responsive elements. There were, however, several elements
representing so-called half-sites. Promoter-reporter constructs
were made in the vector pGL3-B. These included a full-
length promoter and a series of deletion constructs as indicated
(Figure 7B). Two full-length constructs had been made which
differed only in their 3′ sequences: bI3-1L, like all deletion
constructs ended at the transcription start site, whereas bI3-
FL additionally included 10 nucleotides of the 5′ UTR of the
first exon. In all subsequent analyses bI3-1L and bI3-FL behaved
identically.
In a first set of experiments, bI3-FL was transfected
into bovine primary TC, together with either SF1, ERα, or
ERβ expression constructs in varying amounts (Figure 8A).
Whereas, SF1 indicated a significant stimulation independently
of estradiol, ERα showed amarked estradiol-dependent response,
with the estradiol following a typical dose-response relationship
and an EC50 of 1 nM (Figure 8B). Both bovine and human
ERβ expression constructs had been used. Interestingly, neither
construct indicated any stimulatory effect on the bINSL3 gene
promoter (Figure 8A), and additional estradiol in fact appeared
to have either an inhibitory effect (bovine ERβ; Figure 8C),
which was independent of the dose applied, or no impact
(human ERβ; Figure 8D) except at very high concentration
(1µM).
In a second set of experiments, ERα, ERβ (human and
bovine), as well as AR were co-transfected with a full-length
bINSL3 promoter-reporter construct again into bovine primary
TC, and stimulated or not with either androstenedione or
DHT (Figure 9). For ERα, both DHT and androstenedione
showed a statistically significant stimulation of luciferase
activity, though only at higher concentrations (Figures 9A,B).
In fact, androstenedione was able to stimulate luciferase
activity from the full-length construct even in the absence
of added estrogen receptor (Figure 9C), suggesting that this
stimulation may be due to endogenous steroid receptors.
For bovine ERβ, again both DHT and androstenedione
appeared to show a stimulatory effect (Figures 9D,E), which
was absent for the human ERβ (Figure 9F). Co-transfection
of AR indicated again a significant stimulation by DHT,
and also by androstenedione, but for the latter only at
the highest concentration (Figures 9G–I). Results were
equivalent whether using the constructs bI3_FL or bI3_IL
(cf Figures 9H,I).
Finally, deletion promoter-reporter constructs (Figure 7B)
were used in conjunction with expression vectors for either
SF1, ERα, or ERβ (Figure 10). For SF1, activity was achieved
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FIGURE 4 | Effect of estrogen receptor agonist (estradiol; E2) and antagonist (ICI-182,780; ICI) on INSL3 production by bovine theca interna cells in the presence or
absence of the PKA inhibitor H89. (A) Dose-response for H89 in the presence (white bars) or absence (dark bars) of 1 nM E2. (B) Effect on INSL3 production of 10µM
H89 on basal, 8Br-cAMP, ICI and estradiol treated bovine theca interna cells. Statistical significance p < 0.05: a, vs. basal control; b, vs. E2 stimulated control.
FIGURE 5 | Dose-response effects of androgen receptor agonists (A, dihydrotestosterone, DHT. B, androstenedione) and antagonist (C, bicalutamide) on INSL3
production by bovine theca interna cells. *Significantly different from basal control, p < 0.05.
only with the full-length promoter-reporter constructs bI3-FL
and bI3-1L (Figure 10A). All shorter constructs were inactive.
For E2-activated ERα, in contrast, all deletion constructs
except for bI3-8L retained activity (Figure 10B), though notably
construct bI3-4L showed maximum activity, implying an
inhibitory effect in the more extended promoter constructs. As
outlined above (Figure 8C), ERβ differs from ERα by being
active on the full-length bINSL3 promoter-reporter constructs
even in the apparent absence of exogenous ligand. In the
presence of estradiol, the full-length constructs, bI3_FL and
bI3_1L, are consistently more active than all deletion constructs
(Figure 10C).
DISCUSSION
In vivo INSL3 has been shown to be a valuable biomarker
for Leydig cell functional capacity in the male mammal (Ivell
et al., 2013), including in the fetus to monitor the impact of
environmental endocrine disruption on male fetal development
(Anand-Ivell and Ivell, 2014). One of the key features responsible
for its increasing application is the observation that in an acute
context it appears to be secreted in a constitutive manner
and independently of fluctuating LH levels (Ivell and Anand-
Ivell, 2009), though this gonadotropin will influence Leydig
cell differentiation in the long term. However, relatively little
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FIGURE 6 | Dose-response effects of the glucorticoid/progesterone receptor agonists (A, dexamethasone, Dex) and antagonists (B, RU486 and C, onapristone) on
INSL3 production by bovine theca interna cells. *significantly different from basal control, p < 0.05.
FIGURE 7 | (A) Bioinformatic analysis of the upstream promoter region of the bovine INSL3 gene analyzed using TRANSFAC software. Red ellipses indicate putative
binding sites for the transcription factor steroidogenic factor 1 (SF1); diamonds indicate putative steroid receptor half-sites. Exon 1 (X1) and exon 2 (X2) are indicated
as red oblongs on the right. (B) Relative positions of the deletion promoter-reporter constructs used for the transfection experiments including relevant restriction
enzyme cleavage sites.
is known about the regulation of INSL3 by steroid hormones.
Estrogens have been shown to inhibit INSL3 production by
rat and mouse fetal Leydig cells in vivo (Emmen et al., 2000;
Zhang et al., 2009) presumably by impacting on Leydig cell
differentiation. In mouse Leydig cells, estradiol was also shown
to be inhibitory on transfected human and mouse INSL3 gene
promoter-reporter constructs (Lague and Tremblay, 2009), and
appeared to inhibit endogenous INSL3 mRNA levels in these
cells, though another study failed to show such an effect
(Sadeghian et al., 2005). Similarly, androgens have also been
suggested to impact positively on transfected INSL3 promoter-
reporter constructs in mouse Leydig cells, whilst having little or
no effect on the endogenous mRNA (Lague and Tremblay, 2009).
Recently, we have shown that INSL3 is also important for female
reproduction, being an essential component in the follicular
production and regulation of steroid hormones (Anand-Ivell
et al., 2013; Glister et al., 2013). In particular, INSL3 is made
exclusively by the theca interna cells (TC) of growing antral
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FIGURE 8 | (A) Luciferase activity (relative light units, RLU) generated in bovine theca interna cells transfected with the full-length INSL3 promoter-reporter construct
(bI3-FL) in the presence or absence, as indicated, of co-transfected expression constructs for SF1, ERα, hERβ or bERβ at 1x, 2x or 3x concentrations, and 10 nM
estradiol (E2). The basal vector pGL3-B served as negative reporter control; the empty vector p0GH served as control for the expression vectors. (B) Dose-response
relationship for added E2 on the full-length promoter-reporter construct bI3-FL co-transfected with an expression construct for ERα. (C) Dose-response relationship
for added E2 on the full-length promoter-reporter construct bI3-FL co-transfected with an expression construct for bovine ERβ. (D) Dose-response relationship for
added E2 on the full-length promoter-reporter construct bI3-FL co-transfected with an expression construct for human ERβ. *Indicates significant difference from
control (p < 0.05).
follicles and in an autocrine/paracrine manner is responsible for
the generation by these cells of androstenedione (Glister et al.,
2013), which is the key precursor for most follicular steroid
production, including estrogens. In fact, application of siRNA to
substantially reduce the expression by bovine TC of either INSL3
or its specific receptor RXFP2 led to almost complete inhibition
of androstendione production (Glister et al., 2013). Unlike
mature Leydig cells, TC are in a state of continual differentiation
across the estrous cycle, responding to the cyclic changes in
gonadotropin production by the pituitary and probably also to
local hormones from the growing follicle. The present study was
undertaken using the bovine model to examine the way in which
INSL3 from TC might be regulated by steroids from the local
ovarian environment, especially as these might be present in high
and varying local concentrations.
The bovine INSL3 gene on chromosome 7, like that from other
mammals, is immediately preceded in the genome by the JAK3
gene, whose last exon is only 1,800 bp upstream of the INSL3
transcription start site. As indicated for other species, because of
the apparently independent regulation of JAK3, it seems likely
that most regulatory DNA elements will be within those 1,800
bp of the immediate upstream promoter region of the INSL3
gene. Inspection of that region, as well as the entire downstream
region occupied by the INSL3 coding region and intervening
sequence, show there to be no obvious canonical responsive
elements recognizing the nuclear receptors for the sex steroid
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FIGURE 9 | Dose-response effects of different agonists, as indicated, on either bI-FL or bI-1L full-length promoter reporter construct activity (relative light units, RLU)
in bovine theca interna cells in the presence of different co-transfected expression vectors for ERα (A,B), bERβ (D,E), hERβ (F) or the androgen receptor (AR; G,H,I).
The vector p0GH served as negative control (C). *Indicates significant difference from vehicle control (p < 0.05).
hormones. Instead, as in other species there are three responsive
elements for the transcription factor steroidogenic factor 1 (SF1;
Figure 7) besides several so-called estrogen-receptor half-sites.
Firstly, we looked at effects of steroid hormones on
endogenous INSL3 production by cultured bovine TC, as
reflected in peptide secretion. The TC were selected from
mid-phase growing antral follicles so that any variation in
differentiation status at the beginning of culture could be
minimized. These are the cells which are highly steroidogenic,
LH-dependent, and indirectly responsible for the high levels
of estradiol produced by the granulosa cells of the mid-phase
bovine follicle. Unlike for Leydig cells, estradiol had a stimulatory
effect on endogenous INSL3 production with an optimum
in the low nanomolar range. Importantly, by itself the pure
estrogen receptor antagonist, ICI-182,780, was inhibitory on
INSL3 production implying the presence in the cell culture
of endogenous estrogens (estrogen receptor agonists). Like
estradiol, exogenous androstenedione also stimulated INSL3
production, an effect which was similarly inhibited by ICI-
182,780 (not shown). Although androstenedione tends to be
thought of as a weak androgen, in fact it can act not only at the
androgen receptor, but also very effectively at both ERα and ERβ
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FIGURE 10 | Luciferase activity (relative light units, RLU) generated in bovine
theca interna cells transfected with the various deletion-promoter reporter
constructs as indicated in Figure 7. (A) Co-transfected with the expression
vector for SF1. (B) Co-transfected with the expression vector for ERα.
(C) Co-transfected with the expression vector for bovine ERβ.
(Miller et al., 2013). In contrast, the androgen receptor antagonist
bicalutamide had no significant effect on the androstendione-
dependent stimulation of INSL3 production by TC (not shown).
In fact, bicalutamide alone appeared to stimulate INSL3 secretion
at moderate concentrations, though having no effect at lower
and higher concentrations. This would imply that endogenous
androgens, acting through the androgen receptor, may in fact be
inhibiting INSL3 production. This would also be in line with the
results of adding DHT to the cultures, where it appears to have
little or no effect. Finally, addition of the progesterone antagonist
RU486 led to a marked inhibition of INSL3 secretion, implying
the probable involvement also of endogenous progesterone in
INSL3 production, generated via the 14 pathway. Thus, bovine
TC appear to be different from rodent Leydig cells in terms of
the way in which they are regulated by sex steroids. This is not
surprising given the profile of ambient steroids present in the
adult testis. Together with the lack of canonical steroid responsive
elements in the INSL3 gene promoter, this suggests that steroid
action is less likely to be via classical regulatory mechanisms
acting directly on INSL3 gene transcription, but more likely to
be indirect by influencing other aspects of cell metabolism or
differentiation, or using non-classical signaling pathways (Ivell
et al., 2014).
This notion was reinforced also by the experiments using LH
or 8Br-cAMP. As shown previously for Leydig cells (Sadeghian
et al., 2005), and also for bovine TC (Bathgate et al., 1999; Glister
et al., 2013), both substances at low dose had only a modest
stimulatory effect, if at all, whereas high doses, equivalent to
what might be experienced during the LH surge, were inhibitory.
Most significantly, however, any positive effect of low dose LH
or 8Br-cAMP was completely negated by the estrogen receptor
antagonist ICI-182,780. And contrarily, the stimulatory effect
of estradiol on INSL3 secretion could be substantially reduced
by the PKA antagonist H89. These findings place the putative
interaction between the PKA pathway and the estrogen receptor
pathway in the cytoplasm, all of the results together suggesting a
complex systemmuch as has been described for breast or prostate
cancer cells (Migliaccio et al., 2000, 2005).
In order to explore possible direct effects on INSL3 gene
transcription further, we made use in bovine TC of transiently
transfected promoter-reporter constructs derived from the
bovine INSL3 gene together with expression vectors for several
steroid receptors. Here it should be noted that the transfected
constructs were likely to be influenced also by both endogenous
transcription factors as well as by endogenous steroids, and thus
that results need to be interpreted in this context. Generally,
most stimulatory activity appeared to reside in the full-length
promoter-reporter constructs, where it appears that the region of
the most distal SF-1 responsive element at −1,700 bp is playing
a key role. Interestingly, responsiveness to activated ERα appears
to be contributed by most of the promoter region with maximal
effect between −100 and −1,200 bp, a region where previously
specific TC nuclear protein binding had been observed (Suhrbier,
2000). Importantly, ERβ appears to behave differently from ERα.
Over-expression of the former seems to require the full-length
promoter, though curiously its basal activity is inhibited by
addition of estradiol. These experiments need to be regarded
cautiously since the TC used for these experiments still express
endogenous steroid receptors. At higher steroid concentrations
both DHT and androstenedione appeared to stimulate the full-
length promoter-reporter constructs, when co-transfected with
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either ERα, ERβ or the androgen receptor (AR). However, it is
important to note that both exogenous steroids appear to exert
stimulatory effects even when neither added steroid receptors
nor cognate responsive elements are present, implying that these
transfection experiments may be confounded by endogenous
signaling systems. Another important observation from these
experiments is that androstenedione is more effective at lower
concentration via the transfected estrogen receptors (Figure 9;
10–100 nM) than via the androgen receptor (Figure 9; 1,000 nM),
confirming that in this follicular context we should regard this
steroid more as an estrogen than an androgen.
Taken together, these results support a model whereby most
steroid effects may be occurring within the cytoplasm, impacting
on stimulatory pathways which lead either to the specific
distal SF1 site, presumably occupied by SF1, or an analog
such as nur77, and/or to other transcription factors impacting
on the intermediate region of the promoter. There is little
direct evidence to support any specific and direct interaction of
steroid receptors with the bovine INSL3 promoter region. These
results show for mid-cycle bovine TC that estradiol, probably
acting through ERα, stimulates INSL3 gene activity, and that
androstenedione likely acts in a similar way also through estrogen
receptor pathways and not via androgen receptors. Androgens
in contrast, at least with endogenous receptor levels, may inhibit
INSL3 expression, thus explaining the stimulatory impact of the
androgen receptor antagonist bicalutamide. Significantly, low
dose LH or dBr-cAMP is convergent with the estrogen pathway
since the former pathway can be antagonized by ICI-182,780
and reciprocally estrogen-dependent activation of bINSL3 can be
blocked by the PKA inhibitor H89.
The peptide hormone INSL3 is special in that it represents
a major non-steroid-related TC product whose expression is
thereby independent of conventional steroid metabolism and
thus allows some insight into the way local steroids might
influence TC function. It should be noted that the INSL3 gene
promoter is similar in several ways to the promoter regions
of major steroidogenic enzyme genes, such as that for 17α-
hydroxylase, which also relies on a prominent SF1-responsive
element (Sewer et al., 2008) and is stimulated via a PKA-
dependent pathway (Sewer et al., 2008). This study shows that
in the context of follicular development and function there is
a possibility for estradiol (presumably from granulosa cells),
progesterone, and androstenedione (from TC) to positively
influence INSL3 expression, and conversely that androgens such
as testosterone (also from TC) might counter these effects.
Given the role of high levels of estradiol in promoting antral
follicle maturation, this suggests a positive feedforward system
also involving TC and INSL3 to orchestrate and coordinate
antral follicle development. Such a system would give rise to a
steadily increasing concentration of circulating estradiol during
the follicular phase, which would then be interrupted by the LH
surge, when on the one hand cells would luteinize and shift to
a 14 rather than 15 pathway with a high progesterone, low
estradiol environment, and INSL3 from TC would be inhibited.
The latter was shown here in vitro and previously also in vivo
(Bathgate et al., 1996).
Together with our previous results showing that 17α-
hydroxylase expression in bovine theca cells is dependent on
activated RXFP2 (Glister et al., 2013), these results emphasize the
essential importance of an INSL3-RXFP2 positive feedforward
loop, which is further promoted by increasing estrogen (estradiol,
androstenedione) concentrations, not only on INSL3 secretion
but most importantly on steroidogenesis as a whole via
concomitant stimulation of 17α-hydroxylase.
We still understand relatively little about the intracellular
mechanisms within TC which integrate and orchestrate the
various signaling pathways involved in INSL3 production and
action. Their elaboration at themolecular levelmust await further
research.
These results are also relevant for our understanding of
the steroidal consequences in polycystic ovarian syndrome
(PCOS), where antral follicles appear to be arrested in an
early differentiation state, with limited aromatase expression and
high levels of secreted steroid precursors (Franks et al., 2000)
as well as INSL3 (Anand-Ivell et al., 2013). The apparently
higher expression of both 17α-hydroxylase and the LH receptor
within individual theca cells from affected ovaries (Comim et al.,
2013), the consideration that the syndrome may be due to
altered ovarian steroidogenesis (Franks et al., 1999), together
with the association of certain INSL3 polymorphisms with
PCOS incidence (Shaikh et al., 2016), suggest that targeting the
INSL3/RXFP2 system in the ovary could offer a novel therapeutic
intervention.
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